Publikationen von Hannelore Ehrenreich
Alle Typen
Zeitschriftenartikel (248)
1.
Zeitschriftenartikel
5 (3), 101011 (2025)
A comprehensive and standardized pipeline for automated profiling of higher cognition in mice. Cell Reports Methods 2.
Zeitschriftenartikel
29, S. 2979 - 2996 (2024)
Erythropoietin restrains the inhibitory potential of interneurons in the mouse hippocampus. Molecular Psychiatry 3.
Zeitschriftenartikel
27, S. 1934 - 1944 (2024)
Oligodendroglial fatty acid metabolism as a central nervous system energy reserve. Nature Neuroscience 4.
Zeitschriftenartikel
2 (3), S. 228 - 242 (2024)
Tolerability and first hints for potential efficacy of motor‐cognitive training under inspiratory hypoxia in health and neuropsychiatric disorders: A translational viewpoint. Neuroprotection 5.
Zeitschriftenartikel
25 (3), 1759 (2024)
Hypoxia Sensing and Responses in Parkinson’s Disease. International Journal of Molecular Sciences 6.
Zeitschriftenartikel
79, S. 38 - 48 (2024)
Effect of erythropoietin on cognitive side-effects of electroconvulsive therapy in depression: A randomized, double-blind, placebo-controlled trial. European Neuropsychopharmacology 7.
Zeitschriftenartikel
13 (12), 1648 (2023)
Neuroprotective Effects of Moderate Hypoxia: A Systematic Review. Brain Sciences 8.
Zeitschriftenartikel
602 (21), S. 5757 - 5783 (2023)
Mechanisms underlying the health benefits of intermittent hypoxia conditioning. The Journal of Physiology 9.
Zeitschriftenartikel
167 (2), S. 296 - 317 (2023)
Loss of the parkinsonism-associated protein FBXO7 in glutamatergic forebrain neurons in mice leads to abnormal motor behavior and synaptic defects. Journal of Neurochemistry 10.
Zeitschriftenartikel
1 (1), S. 9 - 19 (2023)
Exploiting moderate hypoxia to benefit patients with brain disease: Molecular mechanisms and translational research in progress. Neuroprotection 11.
Zeitschriftenartikel
14, 4777 (2023)
Erythropoietin re-wires cognition-associated transcriptional networks. Nature Communications 12.
Zeitschriftenartikel
12 (15), e029843 (2023)
Unraveling Mechanisms of Cryptogenic Stroke at the Genetic Level: A Systematic Literature Review. Journal of the American Heart Association 13.
Zeitschriftenartikel
618, S. 349 - 357 (2023)
Myelin dysfunction drives amyloid-β deposition in models of Alzheimer's disease. Nature 14.
Zeitschriftenartikel
26 (5), 106701 (2023)
Using brain cell-type-specific protein interactomes to interpret neurodevelopmental genetic signals in schizophrenia. iScience 15.
Zeitschriftenartikel
12, e70792 (2023)
Isolated catatonia-like executive dysfunction in mice with forebrain-specific loss of myelin integrity. eLife 16.
Zeitschriftenartikel
108, S. 135 - 147 (2023)
Factors predisposing to humoral autoimmunity against brain-antigens in health and disease Analysis of 49 autoantibodies in over 7000 subjects. Brain, Behavior, and Immunity 17.
Zeitschriftenartikel
317, 114854 (2022)
For decades against the mainstream – From erythropoietin and hypoxia as novel treatment strategies to deep phenotyping in neuropsychiatric disorders. Psychiatry Research 18.
Zeitschriftenartikel
24, 100494 (2022)
Autoantibodies against NMDAR subunit NR1 disappear from blood upon anesthesia. Brain, Behavior, & Immunity - Health 19.
Zeitschriftenartikel
23 (3), S. 284 - 285 (2022)
A Celebration of the Extraordinary Life of Late Professor Tatiana V. Serebrovskaya (Kyiv, Ukraine) in Advancing Hypoxia Science and Medicine. High Altitude Medicine & Biology 20.
Zeitschriftenartikel
27 (5), S. 2372 - 2379 (2022)
Introducing the brain erythropoietin circle to explain adaptive brain hardware upgrade and improved performance. Molecular Psychiatry